Sean Brynjelsen, Chief Executive Officer at Eton Pharmaceuticals, Inc. (ETON), bought 10,000 shares at $2.10 ($21K) on 2022-09-22, disclosed to the SEC on 2022-09-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| ETON | SELL | 2025-06-05 | $4.8M | — | Filing → |
| ETON | BUY | 2021-08-20 | $43K | — | Filing → |
| ETON | BUY | 2021-06-03 | $30K | — | Filing → |